What You Should Know:
– Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka), a global pharmaceutical company, and Verily Life Sciences LLC (Verily), a precision health technology company, have teamed up to launch a groundbreaking research initiative called “My Mental Health Journey.”
– The longitudinal registry study aims to significantly enhance our understanding of depression and other mental health conditions.
The Power of Real-World Data
My Mental Health Journey will enroll adult participants in the U.S. who are experiencing symptoms of depression. This large-scale observational study will leverage real-world data to provide valuable insights:
- Understanding Depression’s Progression: By tracking participants’ experiences over time, researchers will gain a deeper understanding of how depression evolves.
- Diversity and Inclusion: The study design prioritizes enrolling a diverse population, ensuring research reflects the true spectrum of depression.
Participant Engagement through Technology
Participation in My Mental Health Journey is designed to be convenient and informative:
- Self-Guided Assessments: Participants will periodically complete online surveys about their depression journey.
- Digital Data Collection: Securely shared digital data will contribute valuable real-world information to the study.
- Access to Resources: Participants will receive access to educational resources on depression and related mental health topics.
- Future Research Opportunities: Participants will have a simplified path to participate in future clinical research studies focused on mental health.
Verily Viewpoint: Powering the Study
Verily will utilize its expertise in precision health technology to manage the study through its Verily Viewpoint platform. This platform offers:
- End-to-End Solutions: Verily Viewpoint provides a comprehensive suite of tools for participant recruitment, data collection, and analysis.
- Streamlined User Experience: The platform prioritizes a user-friendly design to ensure a positive experience for participants.
- Multi-modal Data Collection: The platform gathers various data points to create a holistic picture of participants’ experiences.
Availability
The My Mental Health Journey registry is now enrolling participants across the United States. If you or someone you know is experiencing symptoms of depression and is interested in contributing to this vital research effort
“We are excited to help usher in the age of precision for mental health care by leveraging multimodal data to give a more complete picture of a person’s individual journey through treatment,” said Andrew Trister, MD, PhD, chief medical and scientific officer at Verily. “Our work with Otsuka offers the promise to accelerate the development and delivery of innovative treatments for depression to serve the millions of patients in need of safe, effective, and accessible care.”